2019新型冠状病毒及其感染性肺炎  

2019 novel coronavirus(2019-nCoV)and 2019-nCoV pneumonia

作　　者：严杰[1] 李明远[2] 孙爱华 彭宜红[4] Yan Jie;Li Mingyuan;Sun Aihua;Peng Yihong(Department of Pathogen Biology,Zhejiang University School of Medicine,Hangzhou 310058,China;Department of Microbiology,School of Basic Medical Science and Forensic Medicine,Sichuan University of West China,Chengdu 610041,China;School of Basic Medical Science and Forensic Medicine,Hangzhou Medical College,Hangzhou 310053,China;Department of Pathogen Biology,Beijing University School of Basic Medical Science,Beijing 100083,China)

机构地区：[1]浙江大学医学院病原生物学系,杭州310058 [2]四川大学华西基础医学与法医学院,成都610041 [3]杭州医学院基础医学与法医学院,310053 [4]北京大学医学部病原生物学系,100083

出　　处：《中华微生物学和免疫学杂志》2020年第1期1-6,共6页Chinese Journal of Microbiology and Immunology

基　　金：国家自然科学基金(81671974,81772232)。

摘　　要：2019年12月中旬我国湖北省武汉市人群中出现了2019新型冠状病毒(2019-nCoV)感染性肺炎暴发流行,疫情迅速蔓延并播散至全国各个地区以及亚洲、欧洲、大洋州和北美13个国家。为了准确和深入了解2019-nCoV生物学性状、流行特征、致病性、免疫性、微生物学检查和公众防护措施,我们在最新有关文献和国家《新型冠状病毒感染的肺炎诊疗方案》最新版本的基础上,对2019-nCoV及其感染性肺炎进行综述。In the middle of December in 2019,a pneumonia outbreak caused by a new coronavirus,2019 novel coronavirus(2019-nCoV),emerged in the populations in Wuhan city of China.The epidemic spreads rapidly and has been disseminated throughout the country and to 13 other counties in Asia,Europe,Oceania and North America.To accurately and deeply understand the biological characteristics,epidemiological features and pathogenicity of 2019-nCoV and related immunological characteristics,microbiological examinations and public protection measure,this study reviewed 2019-nCoV and 2019-nCoV pneumonia based on the newest relevant literatures and the newest version of National Diagnosis and Treatment Scheme of 2019-nCoV pneumonia.

关 键 词：2019新型冠状病毒 生物学性状 2019新型冠状病毒肺炎 流行特征 

分 类 号：R563[医药卫生—呼吸系统]